Adverse prognostic value of MYBL2 overexpression and association with microRNA-30 family in acute myeloid leukemia patients-Reference-Cited by-同舟云学术

Adverse prognostic value of MYBL2 overexpression and association with microRNA-30 family in acute myeloid leukemia patients

Published:2013-12 Issue:12 Volume:37 Page:1690-1696
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Fuster Óscar,Llop Marta,Dolz Sandra,García Paloma,Such Esperanza,Ibáñez Mariam,Luna Irene,Gómez Inés,López María,Cervera José,Montesinos Pau,Moscardó Federico,Cordón Lourdes,Solves Pilar,de Juan Inmaculada,Palanca Sarai,Bolufer Pascual,Sanz Miguel Ángel,Barragán Eva

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference46 articles.

1. The myb gene family in cell growth, differentiation and apoptosis;Oh;Oncogene,1999

2. Expression of c-myb and B-myb, but not A-myb, correlates with proliferation in human hematopoietic cells;Golay;Blood,1991

3. Growth regulated expression of B-myb in fibroblasts and hematopoietic cells;Reiss;J Cell Physiol,1991

4. B-myb antisense oligonucleotides inhibit proliferation of human hematopoietic cell lines;Arsura;Blood,1992

5. Expression of B-Myb during mouse embryogenesis;Sitzmann;Oncogene,1996

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MYBL2 Drives Prostate Cancer Plasticity: Inhibiting Its Transcriptional Target CDK2 for RB1-Deficient Neuroendocrine Prostate Cancer;Cancer Research Communications;2024-09-01

2. MYBL2 drives prostate cancer plasticity and identifies CDK2 as a therapeutic vulnerability in RB1-loss and neuroendocrine prostate cancer;2024-02-02

3. MYBL2: a novel aggressive biomarker in IDH-mutant Astrocytoma;2024-01-02

4. PCR-Based Strategy for Introducing CRISPR/Cas9 Machinery into Hematopoietic Cell Lines;Cancers;2023-08-25

5. Increased MYBL2 expression in aggressive hormone‐sensitive prostate cancer;Molecular Oncology;2022-10-02